The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Increased transforming growth factor‐β, interleukin‐4, and interferon‐γ in multiple sclerosis
Abstract
The inflammatory nature of multiple sclerosis (MS) implicates the participation of immunoregulatory cytokines, including the T‐helper type 1 (Th1) cell–associated interferon‐σ (IFN‐σ), the Th2 cell–related interleukin‐4 (IL‐4), and the immune response–downregulating cytokine transforming growth factor‐β (TGF‐β), but proof for their involvement in MS has been lacking. By adopting in situ hybridization with complementary DNA oligonucleotide probes for human IFN‐ IL‐4, and TGF‐β, the expression of mRNA for these cytokines was detected in mononuclear cells (MNC) from blood and cerebrospinal fluids. Strongly elevated levels of MNC expressing all three cytokines were found in peripheral blood and at even higher frequencies in cerebrospinal fluid from untreated patients with MS and optic neuritis, i.e., a common first manifestation of MS, compared with patients with other neurological diseases and healthy subjects. In MS and optic neuritis, IL‐4 mRNA expressing cells predominated, followed by TGF‐β– and IFN‐σ–positive cells. Control patients with myasthenia gravis had similarly elevated levels of IFN‐σ and TGF‐β mRNA expressing blood MNC but lower numbers of IL‐4–positive cells. No or slight disability of MS was associated with high levels of TGF‐β mRNA expressing cells, while MS patients with moderate or severe disability had high levels of IFN‐σ–positive cells. IFN‐σ and TGF‐β may have opposing effects in MS, and treatments inhibiting IFN‐σ and/or promoting TGF‐β might ameliorate MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
Schumacher, G. A., Beebe, G., Kibler, R. F., Kurland, L. T., Kurtzke, J. F., McDowell, F., Nagler, B., Sibley, W. A., Tourtellotte, W. W., & Willmon, T. L. (1965) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb20235.x · Cited by 1,438
Cited by
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis
Matusevicius, D., Kivisäkk, P., He, B., Kostulas, N., Özenci, V, Fredrikson, S., & Link, H. (1999) · Multiple Sclerosis Journal · doi:10.1177/135245859900500206 · Cited by 751
Self-citationDemyelination: The Role of Reactive Oxygen and Nitrogen Species
Smith, K. J., Kapoor, R., & Felts, P. A. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00212.x · Cited by 600
Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis
Ishizu, T., Osoegawa, M., Mei, F.-J., Kikuchi, H., Tanaka, M., Takakura, Y., Minohara, M., Murai, H., Mihara, F., Taniwaki, T., et al. (2005) · Brain · doi:10.1093/brain/awh453 · Cited by 334
Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6
Uzawa, A., Mori, M., Arai, K., Sato, Y., Hayakawa, S., Masuda, S., Taniguchi, J., & Kuwabara, S. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510379247 · Cited by 323
Metadata
- Authors
- Link, J., Söderström, M., Olsson, T., Höjeberg, B., Ljungdahl, Å., & Link, H.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1994-09
- Volume
- 36
- Issue
- 3
- Pages
- 379-386
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1597152265
- Cited by
- 162
- References
- 2
- FWCI
- 9.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increased transforming growth factor‐β, interleukin‐4, and interferon‐γ in multiple sclerosis. https://app.cochat.ai/papers/10.1002/ana.410360309
- The paper
- Link, J., Söderström, M., Olsson, T., Höjeberg, B., Ljungdahl, Å., & Link, H. (1994). Increased transforming growth factor‐β, interleukin‐4, and interferon‐γ in multiple sclerosis. Annals of Neurology. https://doi.org/10.1002/ana.410360309
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.